Charlotte Pawlyn

Charlotte Pawlyn | ESH MM 2019 | Personalized treatment for patients with bone disease in MM

Multiple Myeloma Hub

Dr. Charlotte Pawlyn | Results of the Myeloma XI study

Multiple Myeloma Hub

Dr. Charlotte Pawlyn | ASH 2017 | Pre-clinical novel immunotherapeutic strategies in MM

Multiple Myeloma Hub

Charlotte Pawlyn | EHA 2018 | Results from the Myeloma XI trial

Multiple Myeloma Hub

Introduction to novel treatments

Myeloma XI: early relapse exploratory analysis

VJHemOnc – Video Journal of Hematology & HemOnc

MPE Masterclass 2022 | Myeloma treatment updates

Myeloma Patients Europe

Insights into the Myeloma XIV/FiTNEss trial: frailty-adjusted therapy in transplant-ineligible NDMM

VJHemOnc – Video Journal of Hematology & HemOnc

MPE Masterclass 2022 | What role does transplantation still play in the treatment of myeloma?

Myeloma Patients Europe

Early career experiences of clinical trials research - clinical and academic perspectives

UKMRA-MUK-Concept and Access Research Programme

Clinical trial development in multiple myeloma: considerations for hematologists

VJHemOnc – Video Journal of Hematology & HemOnc

Masterclass 2023 | CAR-T updates, challenges, and the future

Myeloma Patients Europe

Novel targets in 2022

VJHemOnc – Video Journal of Hematology & HemOnc

Results of the Myeloma XI study, a quadruplet regimen for transplant eligible patients

Updates from Myeloma XI trial

Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients

Activating the immune system with CELMoDs to treat multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myelo...

Immunomodulatory drugs

COMY live 2020 - Sessions 17

International Academy for Clinical Hematology IACH